diabetes management

Integrating Fitbit into the platform provides Health2Sync users with a more holistic view of their health, which can support them in making healthy lifestyle choices to better manage their condition.

 These three tools that find the middle ground between breakthrough technology and user-friendly interfaces.

At the 79th Annual Scientific Sessions of the American Diabetes Association in San Francisco, pharma giant Roche and India-based digital therapeutics company Wellthy Therapeutics presented real world data of improved diabetes care outcomes in a South Asian population when patients followed prescribed plan of medication and lifestyle modification in conjunction with a combination therapy of self-monitoring blood glucose device and a clinically validated digital therapeutic (DTx).

The company hopes the well-known consumer brand will make its program more accessible.

Health2Sync and Novo Nordisk Pharma Ltd.

Dexcom announced a slew of announcements this morning including an integration with Google Fit, a feature that lets users share their readings with 10 people and a technical inquiries feature. 

Patients using the platform will be able to share their EHR and medication history with One Drop coaches through the Health Records feature. 

The company has also hired the former VA head of mental health services and the former CEO of Ginger.io.

The Sugar.IQ digital diabetes assistant will use AI analytics to predict users' low blood sugar risk within the next one to four hours.

The SurroSense Rx system will be available to Onduo's members in 2019.